Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism
- PMID: 2685007
- DOI: 10.1210/jcem-69-6-1127
Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism
Abstract
Administration of human GH to GH-deficient patients has yielded conflicting results concerning its impact on thyroid function, ranging from increased resting metabolic rate to induction of hypothyroidism. However, most studies have been casuistic or uncontrolled and have used pituitary-derived GH of varying purity, often contaminated with TSH. Therefore, we conducted a double blind, placebo-controlled cross-over study of the effect of 4 months of biosynthetic human GH therapy (Norditropin; 2 IU/m2.day) on thyroid function in GH-deficient adults (8 females and 14 males; mean +/- SE age, 23.8 +/- 1.2 yr). One group (I) was euthyroid without T4 substitution (n = 13), whereas the other (group II) received T4 (n = 9). Serum T4 (nanomoles per L) decreased in both groups after GH treatment [group I, 100 +/- 8 (mean +/- SE) vs. 89 +/- 8 (P less than 0.01); group II, 145 +/- 18 vs. 115 +/- 10 (P less than 0.05)]. Conversely, GH treatment caused an increase in serum T3 (nanomoles per L) in both groups [group I, 1.9 +/- 0.1 vs. 2.0 +/- 0.1 (P less than 0.1); group II, 1.7 +/- 0.1 vs. 1.9 +/- 0.1 (P less than 0.05)]. Similar changes were seen in serum free T4 and T3. The serum T3 level during the placebo period of group I was significantly lower than that in an age-matched reference group (P less than 0.02). Serum rT3 (nanomoles per L) was low in group I and decreased significantly, as in group II, after GH treatment [group I, 0.26 +/- 0.02 (placebo) vs. 0.20 +/- 0.02 (GH; P less than 0.01); group II, 0.38 +/- 0.05 (placebo) vs. 0.29 +/- 0.02 (GH; P less than 0.01)]. Serum TSH decreased in both groups during GH therapy, though not significantly. Serum thyroglobulin was unaltered and did not differ from that in the reference group. In conclusion, our data are consistent with a GH-induced enhancement of peripheral deiodination of T4 to T3. GH thus seems to play an important role, either directly or indirectly, in the regulation of peripheral T4 metabolism.
Similar articles
-
Thyroid function during growth hormone therapy.Horm Res. 1992;38 Suppl 1:63-7. doi: 10.1159/000182572. Horm Res. 1992. PMID: 1295815
-
Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children.Clin Endocrinol (Oxf). 2000 Aug;53(2):183-9. doi: 10.1046/j.1365-2265.2000.01071.x. Clin Endocrinol (Oxf). 2000. PMID: 10931099
-
Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults.Clin Endocrinol (Oxf). 1994 Nov;41(5):609-14. doi: 10.1111/j.1365-2265.1994.tb01826.x. Clin Endocrinol (Oxf). 1994. PMID: 7828350
-
Growth hormone and thyroid function: is secondary thyroid failure underdiagnosed in growth hormone deficient patients?Thyroidology. 1994 Dec;6(3):73-9. Thyroidology. 1994. PMID: 7544998 Review.
-
Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism.Nucl Med Commun. 2009 Aug;30(8):586-93. doi: 10.1097/MNM.0b013e32832c79e0. Nucl Med Commun. 2009. PMID: 19491714
Cited by
-
The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH?Endocrinology. 2020 Aug 1;161(8):bqaa097. doi: 10.1210/endocr/bqaa097. Endocrinology. 2020. PMID: 32556100 Free PMC article.
-
The effects of recombinant human growth hormone therapy on thyroid function in pediatric patients with growth hormone deficiency.Transl Pediatr. 2021 Apr;10(4):851-859. doi: 10.21037/tp-20-401. Transl Pediatr. 2021. PMID: 34012834 Free PMC article.
-
Human growth hormone doping in sport.Br J Sports Med. 2006 Jul;40 Suppl 1(Suppl 1):i35-9. doi: 10.1136/bjsm.2006.027573. Br J Sports Med. 2006. PMID: 16799101 Free PMC article. Review.
-
The metabolic consequences of thyroxine replacement in adult hypopituitary patients.Pituitary. 2012 Dec;15(4):495-504. doi: 10.1007/s11102-011-0356-6. Pituitary. 2012. PMID: 22038030
-
Thyroid hormones and growth hormone secretion.J Endocrinol Invest. 1992 Apr;15(4):313-30. doi: 10.1007/BF03348744. J Endocrinol Invest. 1992. PMID: 1512425 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical